MediPharm Labs Stock (TSXV: LABS) (OTCQX: MEDIF) - Investor Dashboard
MediPharm Labs – Management Team
Patrick McCutcheon, President and CEO
Before founding MediPharm Labs, Pat enjoyed a 15-year career in the pharmaceutical industry in top sales roles, successfully launching a wide range of medical products. He most recently worked at Jansen Pharmaceuticals (Johnson & Johnson) where he led the Hospital Division for Renal and Mental Health products. Pat’s foresight in creating a business that focuses on advanced cannabis concentrates bodes well for medical research, investors and consumers alike. Pat holds an Honors Bachelor of Science degree in biology from the University of Western Ontario.
Chris Hobbs, Chief Financial Officer
Over the past 18 years, Chris has acted as Chief Financial Officer for several private and public companies operating in the resource, health sciences, and technology sectors. Chris is a member of the Chartered Accountants of Ontario and holds a Bachelor of Business Administration from the Schulich School of Business at York University.
David Mayers, Chief Operating Officer
David has more than 25 years of pharmaceutical leadership experience. He began his career as a chemist at SmithKline Beecham (now GlaxoSmithKline). He most recently served as the COO of Impopharma Inc. David earned his Hons. BSc in biological science from the University of Guelph and his MBA from the Rotman School of Business at the University of Toronto.
Sybil Taylor, Chief Marketing Officer
A 25-year marketing veteran, Sybil has brought premium consumer brands to life by developing innovative customer-focused marketing strategies. She launched Steam Whistle Pilsner in 2000 as a pioneering upstart and helped it grow to the largest craft beer brand in Canada. As CMO at Nuuvera Canada, Sybil was a senior contributor to this Canadian Cannabis start-up via strategic planning and brand development for medical and recreational brands. Sybil has been part of senior teams in two of Canada’s Best Managed Companies, and through CSR initiatives, she has brought numerous awards and public profile to her managed brands.
Braden Fenske, Chief Strategy Officer
In his role as Chief Strategy Officer, Braden is responsible for driving the company’s strategic corporate initiatives. He has 20 years of experience in the global healthcare industry and adult beverage space. Prior to joining MediPharm, Braden was the Group Product Director, Global Strategic marketing for Biosense Webster Inc., a J&J Company. He earned a bachelor’s degree in commerce from the University of Alberta.
Warren Everitt, Director of MediPharm Labs Australia
Warren has 15 years of experience in sales, marketing, and consulting for major companies. Prior to joining MediPharm Labs, he built an Asia Pacific presence for a large international digital marketing agency.
Significant Insider Ownership
Patrick McCutcheon, CEO
9.33 million shares
Christopher Hobbs, COO
Keith Strachan, VP, Business Development
7.48 million shares
Ahmed Shehata, General Counsel
3.17 million shares
New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Medipharm Labs, Inc. is a client of NCV Media, LLC. Read our full disclaimer.